NSW Premier's Awards for Outstanding Cancer Research

An annual NSW research awards program that celebrates excellence and innovation in cancer research.

NSW Premier's Awards for Outstanding Cancer Research

The NSW Premier’s Awards for Outstanding Cancer Research, presented by the Cancer Institute NSW, honours the achievements of individuals and teams working across the cancer research sector. It is the leading NSW awards program to celebrate excellence and innovation in cancer research.

In response to our ever-changing environment, the NSW Premier’s Awards will be happening differently this year. Further information will be provided in September.

The following four awards will be presented to those outstanding researchers working to lessen the impact of cancer in NSW. 

Jump to:

Outstanding Cancer Researcher of the Year Outstanding Cancer Research Fellow
Outstanding Cancer Clinical Trials Unit Wildfire Highly Cited Publicationz


Awards by nomination

Please submit nominations to the Grants Team by 5pm Wednesday, 30 September 2020 via a registered administering institution.

Outstanding Cancer Researcher of the Year

The Outstanding Cancer Researcher of the Year Award recognises an individual researcher who has made an active, outstanding, sustained contribution to any field of cancer research in NSW; has a record of substantive and noteworthy publications; and has supported, developed and mentored cancer researchers.

The successful award recipient will receive a prize of $50,000 to assist their research endeavours, and a commemorative award.


This is an individual award. Nominations may be made by an individual who is or has been affiliated with any institution involved in cancer research or cancer medicine in NSW. Nominees cannot nominate themselves for this award.
 

Wildfire Highly Cited Publication

The Wildfire Highly Cited Publication Award recognises a NSW researcher, or team of researchers, who has made a significant difference to cancer care or research practice. This award will be presented to an individual, or research team, for a highly cited publication.

The recipient's contributions will have had a lasting impact on the cancer field and can demonstrate sustained progress against cancer.

The successful award recipient(s) will receive a prize of $10,000 to assist their research endeavours, and a commemorative award.


This is an individual award or team award. Nominations may be made by an individual, or research team who is or has been affiliated with any institution involved in cancer research or cancer medicine in NSW. Nominees can nominate themselves or their team for this award. 
 


Awards by selection

Outstanding Cancer Research Fellow

The Outstanding Cancer Research Fellow Award will be presented to an early career researcher who has demonstrated exceptional research progress over the previous calendar year.

The Outstanding Cancer Research Fellow is assessed by a review of the annual progress reports and final reports as submitted in 2020.

The shortlisted Fellows will be assessed by an independent, external Review Committee of the Cancer Institute NSW.

The successful award recipient will receive a prize of $10,000 towards their research endeavours, and a commemorative award.

Outstanding Cancer Clinical Trials Unit

Making NSW a destination of choice for cancer clinical trials is one of the strategies of the NSW Cancer Plan.

The Cancer Institute NSW Clinical Trials Program supports Clinical Trial Units by funding Local Health Districts, Speciality Health Networks and Private Institutions for enrolments to investigator initiated cancer clinical trials and works collaboratively to develop a strategic approach for the selection and implementation of cancer clinical trials relevant to their population.

The best performing Cancer Clinical Trial Unit is selected for this award through the data held in the Cancer Institute NSW Clinical Trials Portal for the period of 1 July 2019 to 30 June 2020.

The successful Clinical Trial Unit will receive a prize of $10,000 towards the activities of the Cancer Clinical Trials Unit, and a commemorative award.